Oncotarget Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more June 20, 2024
Oncotarget Trending with Impact: Review of HER2 Variants in Breast Cancer Tumors This review compiles splice variations in HER2 breast cancer, specifically in the context of the... read more December 31, 2020
Oncotarget Trending with Impact: Exacta® Guides Treatment and Identifies HER2 In a case presentation paper, Encyclopedic Tumor Analysis guided researchers in identifying HER2 overexpression in... read more November 20, 2020